Suan, Rachel .

HRN: 28-60-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
CEFUROXIME 750MG (VIAL)
02/20/2026
02/26/2026
IV
750mg
Q8
TBI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: